FHIT oncosuppressor gene expression profile in human anal cancers

International Journal of Biological Markers

Volumn 22, Issue 1, 2007, Pages 39-42

  Zucchini, C ^a   Concu, M ^a   Martini, F ^b   Morelli, C ^b   Salfi, N ^c   Carinci, P ^a   Tognon, M ^b   Caramelli, Elisabetta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anal cancer; FHIT gene; FRA3B; Mutational screening; RT PCR

Indexed keywords

COMPLEMENTARY DNA; FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANUS CANCER; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 34248364283     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.3425     Document Type: Article

References (12)

1. Mori M, Mimori K, Shiraishi T, et al. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000; 60: 1177-82.
2. Shimada Y, Sato F, Watanabe G, et al. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history. Cancer 2000; 89: 5-11.
3. Caselli M, Marchisio M, Gaudio M, et al. Fhit protein expression in human gastric cancer and related precancerous lesions. Oncol Rep 2001; 8: 1233-7.
4. Lee SH, Kim WH, Kim HK, et al. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem Biophys Res Commun 2001; 284: 850-5.
5. Kawaguchi K, Yashima K, Koda M, et al. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with MIh1 expression and gastric phenotype. Br J Cancer 2004; 90: 672-7.
6. Mori M, Mimori K, Masuda T, et al. Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma. Cancer Res 2001; 61: 7379-82.
7. Sarli L, Bottarelli L, Azzoni C, et al. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. Eur J Cancer 2004; 40: 1581-8.
8. Sorio C, Baron A, Orlandini S, et al. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res 1999; 59: 1308-14.
9. Huebner K, Garrison PN, Barnes LD, Croce CM. The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 1998; 32: 7-31.
10. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004; 5: 149-57.
11. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
12. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated (t3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84: 587-97.